Tel Aviv - Delayed Quote ILA
Evogene Ltd. (EVGN.TA)
420.50
-2.30
(-0.54%)
At close: April 23 at 5:24:34 PM GMT+3
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
8,511
8,511
5,640
1,675
930
Cost of Revenue
2,683
2,683
1,692
909
767
Gross Profit
5,828
5,828
3,948
766
163
Operating Expense
28,038
28,038
30,456
27,707
31,116
Operating Income
-22,210
-22,210
-26,508
-26,941
-30,953
Net Non Operating Interest Income Expense
409
409
975
-237
-270
Other Income Expense
3,756
3,756
-454
-2,576
791
Pretax Income
-18,045
-18,045
-25,987
-29,754
-30,432
Tax Provision
9
9
-33
90
13
Net Income Common Stockholders
-16,485
-16,485
-23,879
-26,638
-27,793
Diluted NI Available to Com Stockholders
-16,485
-16,485
-23,879
-26,638
-27,793
Basic EPS
-2.89
--
-5.20
-6.44
-6.90
Diluted EPS
-2.89
--
-5.20
-6.44
-6.90
Basic Average Shares
5,697.25
--
4,589.39
4,141.84
4,043.33
Diluted Average Shares
5,697.25
--
4,589.39
4,141.84
4,043.33
Total Operating Income as Reported
-22,210
-22,210
-26,508
-26,941
-30,953
Total Expenses
30,721
30,721
32,148
28,616
31,883
Net Income from Continuing & Discontinued Operation
-16,485
-16,485
-23,879
-26,638
-27,793
Normalized Income
-19,407.15
-19,407.15
-23,425.58
-24,654.48
-28,402.07
Interest Income
957
957
1,248
182
291
Interest Expense
63
63
115
165
315
Net Interest Income
409
409
975
-237
-270
EBIT
-17,982
-17,982
-25,872
-29,589
-30,117
EBITDA
-15,478
-15,478
-23,260
-27,009
-27,883
Reconciled Cost of Revenue
2,683
2,683
1,692
909
767
Reconciled Depreciation
2,504
2,504
2,612
2,580
2,234
Net Income from Continuing Operation Net Minority Interest
-16,485
-16,485
-23,879
-26,638
-27,793
Total Unusual Items Excluding Goodwill
3,795
3,795
-454
-2,576
791
Total Unusual Items
3,795
3,795
-454
-2,576
791
Normalized EBITDA
-19,273
-19,273
-22,806
-24,433
-28,674
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
872.85
872.85
-0.58
-592.48
181.93
12/31/2021 - 6/13/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CGEN.TA Compugen Ltd.
536.60
+3.39%
MLECW Moolec Science SA
0.0170
+65.05%
PPBT.TA Purple Biotech Ltd
5.10
+2.00%
CANF.TA Can-Fite BioPharma Ltd.
1.5000
-6.25%
ENLV.TA Enlivex Therapeutics Ltd.
330.60
-0.57%
SNSE Sensei Biotherapeutics, Inc.
0.3701
+5.74%
RADX Radiopharm Theranostics Limited
4.0500
-3.34%
688238.SS Obio Technology (Shanghai) Corp., Ltd.
5.83
-1.02%
CGEN Compugen Ltd.
1.4400
-1.37%
MLEC Moolec Science SA
0.6145
-9.65%